Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neurogesx Inc (NGSX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neurogesx Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1385830.
Total stock buying since 2010: $6,202,734.
Total stock sales since 2010: $4,735,456.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2013 | 0 | $0 | 0 | $0 | 25,000 | $0 |
2012 | 0 | $0 | 0 | $0 | 22,500 | $0 |
2011 | 3,494,472 | $5,774,276 | 1,557,839 | $4,706,263 | 0 | $0 |
2010 | 69,101 | $428,458 | 3,500 | $29,193 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2013-01 | 0 | $0 | 0 | $0 | 25,000 | $0 |
2012-12 | 0 | $0 | 0 | $0 | 3,750 | $0 |
2012-11 | 0 | $0 | 0 | $0 | 18,750 | $0 |
2011-08 | 0 | $0 | 326,936 | $679,422 | 0 | $0 |
2011-07 | 3,488,372 | $5,755,812 | 0 | $0 | 0 | $0 |
2011-06 | 0 | $0 | 848,265 | $2,493,670 | 0 | $0 |
2011-05 | 6,100 | $18,464 | 5,114 | $14,373 | 0 | $0 |
2011-03 | 0 | $0 | 371,716 | $1,496,345 | 0 | $0 |
2011-02 | 0 | $0 | 5,808 | $22,453 | 0 | $0 |
2010-09 | 30,000 | $165,000 | 0 | $0 | 0 | $0 |
2010-08 | 7,500 | $44,525 | 0 | $0 | 0 | $0 |
2010-07 | 4,100 | $26,199 | 0 | $0 | 0 | $0 |
2010-06 | 27,501 | $192,734 | 0 | $0 | 0 | $0 |
2010-05 | 0 | $0 | 3,500 | $29,193 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-01-01 | Martell Ron (President and CEO) | Option Ex | 25,000 | .00 | 0 |
2012-12-01 | Ghiglieri Stephen F (Exec. V.P., COO & CFO) | Option Ex | 3,750 | .00 | 0 |
2012-11-09 | Peroutka Stephen J (Vice President and CMO) | Option Ex | 18,750 | .00 | 0 |
2011-08-10 | Senator Ron | Sale | 82,109 | 2.00 | 164,546 |
2011-08-10 | M. Arkin (1999) Ltd. | Sale | 82,109 | 2.00 | 164,546 |
2011-08-09 | Senator Ron | Sale | 81,359 | 2.15 | 175,165 |
2011-08-09 | M. Arkin (1999) Ltd. | Sale | 81,359 | 2.15 | 175,165 |
2011-07-26 | Nelsen Robert (Director) | Buy | 1,744,186 | 1.65 | 2,877,906 |
2011-07-21 | Nelsen Robert (Director) | Buy | 1,744,186 | 1.65 | 2,877,906 |
2011-06-27 | Senator Ron | Sale | 1,079 | 2.10 | 2,270 |
2011-06-27 | M. Arkin (1999) Ltd. | Sale | 1,079 | 2.10 | 2,270 |
2011-06-24 | Senator Ron | Sale | 7,499 | 2.10 | 15,755 |
2011-06-24 | M. Arkin (1999) Ltd. | Sale | 7,499 | 2.10 | 15,755 |
2011-06-23 | Senator Ron | Sale | 50,000 | 2.09 | 104,550 |
2011-06-23 | M. Arkin (1999) Ltd. | Sale | 50,000 | 2.09 | 104,550 |
2011-06-16 | Senator Ron | Sale | 399,002 | 3.03 | 1,210,572 |
2011-06-16 | M. Arkin (1999) Ltd. | Sale | 300,000 | 3.21 | 961,500 |
2011-06-03 | Senator Ron | Sale | 3,300 | 2.22 | 7,326 |
2011-06-02 | Senator Ron | Sale | 17,807 | 2.36 | 42,095 |
2011-06-01 | Senator Ron | Sale | 11,000 | 2.46 | 27,027 |
2011-05-18 | Tobias Jeffrey K (EVP Research & Dev & CMO) | Sale | 1,115 | 2.82 | 3,144 |
2011-05-17 | Tobias Jeffrey K (EVP Research & Dev & CMO) | Sale | 1,333 | 2.73 | 3,639 |
2011-05-16 | Tobias Jeffrey K (EVP Research & Dev & CMO) | Sale | 1,333 | 2.84 | 3,785 |
2011-05-13 | Tobias Jeffrey K (EVP Research & Dev & CMO) | Sale | 733 | 2.81 | 2,059 |
2011-05-12 | Tobias Jeffrey K (EVP Research & Dev & CMO) | Sale | 600 | 2.91 | 1,746 |
2011-05-06 | Ghiglieri Stephen F (EVP, COO & CFO) | Buy | 6,100 | 3.03 | 18,464 |
2011-03-28 | Senator Ron | Sale | 12,316 | 4.07 | 50,138 |
2011-03-25 | M. Arkin (1999) Ltd. | Sale | 120,000 | 4.02 | 482,880 |
2011-03-24 | Senator Ron | Sale | 152,600 | 4.05 | 617,419 |
2011-03-24 | M. Arkin (1999) Ltd. | Sale | 32,600 | 4.07 | 132,616 |
2011-03-23 | Senator Ron | Sale | 33,800 | 4.01 | 135,436 |
2011-03-23 | M. Arkin (1999) Ltd. | Sale | 12,100 | 4.01 | 48,533 |
2011-03-01 | Senator Ron | Sale | 8,300 | 3.53 | 29,323 |
2011-02-28 | Senator Ron | Sale | 5,808 | 3.87 | 22,453 |
2010-09-09 | Arkin Moshe (Other) | Buy | 30,000 | 5.50 | 165,000 |
2010-08-19 | Markels Michael (Senior VP,Commercial & Bus Dev) | Buy | 2,500 | 5.75 | 14,370 |
2010-08-10 | Goodwin Bradford S (Director) | Buy | 5,000 | 6.03 | 30,155 |
2010-07-01 | Senator Ron (Other) | Buy | 4,100 | 6.39 | 26,199 |
2010-06-30 | Senator Ron (Other) | Buy | 10,501 | 6.65 | 69,852 |
2010-06-28 | Senator Ron (Other) | Buy | 7,000 | 7.16 | 50,148 |
2010-06-08 | Goodwin Bradford S (Director) | Buy | 4,000 | 7.18 | 28,724 |
2010-06-07 | Goodwin Bradford S (Director) | Buy | 6,000 | 7.33 | 44,010 |
2010-05-24 | Bienaime Jean Jacques (Director) | Sale | 2,000 | 8.06 | 16,128 |
2010-05-19 | Bienaime Jean Jacques (Director) | Sale | 1,500 | 8.71 | 13,065 |
Insider trading activities including stock purchases, stock sales, and option exercises of NGSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neurogesx Inc (symbol NGSX, CIK number 1385830) see the Securities and Exchange Commission (SEC) website.